Clark David Michael 4
4 · AMICUS THERAPEUTICS, INC. · Filed Jan 6, 2025
Insider Transaction Report
Form 4
Clark David Michael
Chief People Officer
Transactions
- Tax Payment
Common Stock
2025-01-02$9.31/sh−5,381$50,097→ 261,967 total - Tax Payment
Common Stock
2025-01-03$9.41/sh−11,987$112,798→ 319,208 total - Award
Stock Options (right to buy)
2025-01-03+125,430→ 125,430 totalExercise: $9.41Exp: 2035-01-03→ Common Stock (125,430 underlying) - Award
Common Stock
2025-01-03+69,228→ 331,195 total - Tax Payment
Common Stock
2025-01-04$9.41/sh−2,692$25,332→ 316,516 total
Footnotes (2)
- [F1]Granted in the form of Restricted Stock Units ("RSUs"), these RSUs will vest in four equal annual installments beginning on January 3, 2026 and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock.
- [F2]These options vest and become exercisable in a series of installments over a four year period with 25% vesting one year after the date of grant and the remaining 75% vesting ratably each month thereafter.